ID   FLII_HUMAN              Reviewed;        1269 AA.
AC   Q13045;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   21-MAR-2012, entry version 126.
DE   RecName: Full=Protein flightless-1 homolog;
GN   Name=FLII; Synonyms=FLIL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=97321044; PubMed=9177775; DOI=10.1006/geno.1997.4709;
RA   Campbell H.D., Fountain S., Young I.G., Claudianos C., Hoheisel J.D.,
RA   Chen K.-S., Lupski J.R.;
RT   "Genomic structure, evolution, and expression of human FLII, a
RT   gelsolin and leucine-rich-repeat family member: overlap with LLGL.";
RL   Genomics 42:46-54(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-11, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-1269.
RC   TISSUE=Hippocampus;
RX   MEDLINE=94068608; PubMed=8248259; DOI=10.1073/pnas.90.23.11386;
RA   Campbell H.D., Schimansky T., Claudianos C., Ozsarac N.,
RA   Kasprzak A.B., Cotsell J.N., Young I.G., de Couet H.G., Miklos G.L.G.;
RT   "The Drosophila melanogaster flightless-I gene involved in
RT   gastrulation and muscle degeneration encodes gelsolin-like and
RT   leucine-rich repeat domains and is conserved in Caenorhabditis elegans
RT   and humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:11386-11390(1993).
RN   [5]
RP   INTERACTION WITH ACTIN AND LRRFIP1, AND TISSUE SPECIFICITY.
RX   MEDLINE=98192575; PubMed=9525888; DOI=10.1074/jbc.273.14.7920;
RA   Liu Y.-T., Yin H.L.;
RT   "Identification of the binding partners for flightless I, a novel
RT   protein bridging the leucine-rich repeat and the gelsolin
RT   superfamilies.";
RL   J. Biol. Chem. 273:7920-7927(1998).
RN   [6]
RP   INTERACTION WITH LRRFIP1.
RX   MEDLINE=98337902; PubMed=9671805; DOI=10.1093/nar/26.15.3460;
RA   Wilson S.A., Brown E.C., Kingsman A.J., Kingsman S.M.;
RT   "TRIP: a novel double stranded RNA binding protein which interacts
RT   with the leucine rich repeat of flightless I.";
RL   Nucleic Acids Res. 26:3460-3467(1998).
RN   [7]
RP   INTERACTION WITH LRRFIP1 AND LRRFIP2.
RC   TISSUE=Skeletal muscle;
RX   MEDLINE=99296829; PubMed=10366446; DOI=10.1006/geno.1999.5817;
RA   Fong K.S.K., de Couet H.G.;
RT   "Novel proteins interacting with the leucine-rich repeat domain of
RT   human flightless-I identified by the yeast two-hybrid system.";
RL   Genomics 58:146-157(1999).
RN   [8]
RP   FUNCTION, INTERACTION WITH CARM1; ESR1; THRB; NCOA2 AND ACTL6A, AND
RP   MUTAGENESIS OF GLU-586 AND GLY-603.
RX   PubMed=14966289; DOI=10.1128/MCB.24.5.2103-2117.2004;
RA   Lee Y.-H., Campbell H.D., Stallcup M.R.;
RT   "Developmentally essential protein flightless I is a nuclear receptor
RT   coactivator with actin binding activity.";
RL   Mol. Cell. Biol. 24:2103-2117(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436 AND SER-856, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406 AND SER-856, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION AT SER-436 AND THR-818, AND INTERACTION WITH SGK3.
RX   PubMed=19293151; DOI=10.1074/jbc.M807770200;
RA   Xu J., Liao L., Qin J., Xu J., Liu D., Songyang Z.;
RT   "Identification of Flightless-I as a substrate of the cytokine-
RT   independent survival kinase CISK.";
RL   J. Biol. Chem. 284:14377-14385(2009).
RN   [17]
RP   INTERACTION WITH LRRFIP1; LRRFIP2 AND MYD88.
RX   PubMed=19265123; DOI=10.4049/jimmunol.0802260;
RA   Dai P., Jeong S.Y., Yu Y., Leng T., Wu W., Xie L., Chen X.;
RT   "Modulation of TLR signaling by multiple MyD88-interacting partners
RT   including leucine-rich repeat Fli-I-interacting proteins.";
RL   J. Immunol. 182:3450-3460(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-856, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: May play a role as coactivator in transcriptional
CC       activation by hormone-activated nuclear receptors (NR) and acts in
CC       cooperation with NCOA2 and CARM1. Involved in estrogen hormone
CC       signaling. Involved in early embryonic development (By
CC       similarity). May play a role in regulation of cytoskeletal
CC       rearrangements involved in cytokinesis and cell migration.
CC   -!- SUBUNIT: Interacts with actin, ACTL6A, NCOA2, CARM1 and MYD88.
CC       Interacts with LRRFIP1 and LRRFIP2. Upon LPS stimulation, LRRFIP2
CC       competes for MYD88-binding. LRRFIP1 constitutively blocks the
CC       interaction with MyD88, even in the absence of LPS. Interacts with
CC       the nuclear receptors ESR1 and THRB. Interacts with SGK3.
CC   -!- INTERACTION:
CC       Q32MZ4:LRRFIP1; NbExp=2; IntAct=EBI-351549, EBI-1369100;
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity). Cytoplasm,
CC       cytoskeleton (By similarity). Cytoplasm, cytoskeleton, centrosome
CC       (By similarity). Note=Colocalizes to actin-rich structures in
CC       blastocysts and, together with HRAS1, RHOA and CDC42, in migrating
CC       fibroblasts. Localizes to centrosomes (By similarity).
CC   -!- TISSUE SPECIFICITY: Strongest expression in skeletal muscle with
CC       high expression also in the heart and lung.
CC   -!- DISEASE: Deletion of the FLII gene may be a cause of Smith-Magenis
CC       syndrome (SMS) [MIM:182290]. It is a contiguous gene deletion
CC       syndrome involving developmental abnormalities and mental
CC       retardation. The spectrum of clinical findings includes short
CC       stature, brachydactyly, developmental delay, dysmorphic features,
CC       sleep disturbances, and behavioral problems.
CC   -!- SIMILARITY: Contains 5 gelsolin-like repeats.
CC   -!- SIMILARITY: Contains 15 LRR (leucine-rich) repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U80184; AAC02796.1; -; Genomic_DNA.
DR   EMBL; BC025300; AAH25300.1; -; mRNA.
DR   EMBL; U01184; AAC03568.1; -; mRNA.
DR   IPI; IPI00031023; -.
DR   PIR; A49674; A49674.
DR   RefSeq; NP_002009.1; NM_002018.3.
DR   UniGene; Hs.513984; -.
DR   ProteinModelPortal; Q13045; -.
DR   SMR; Q13045; 4-395, 493-839, 905-1265.
DR   IntAct; Q13045; 6.
DR   MINT; MINT-1399971; -.
DR   STRING; Q13045; -.
DR   PhosphoSite; Q13045; -.
DR   DMDM; 18202493; -.
DR   PeptideAtlas; Q13045; -.
DR   PRIDE; Q13045; -.
DR   DNASU; 2314; -.
DR   Ensembl; ENST00000327031; ENSP00000324573; ENSG00000177731.
DR   GeneID; 2314; -.
DR   KEGG; hsa:2314; -.
DR   UCSC; uc002gsq.1; human.
DR   CTD; 2314; -.
DR   GeneCards; GC17M018088; -.
DR   H-InvDB; HIX0013598; -.
DR   HGNC; HGNC:3750; FLII.
DR   HPA; CAB016132; -.
DR   HPA; HPA007084; -.
DR   HPA; HPA008903; -.
DR   MIM; 182290; phenotype.
DR   MIM; 600362; gene.
DR   neXtProt; NX_Q13045; -.
DR   Orphanet; 819; Smith-Magenis syndrome.
DR   PharmGKB; PA28171; -.
DR   eggNOG; COG4886; -.
DR   GeneTree; ENSGT00620000087896; -.
DR   HOGENOM; HBG357462; -.
DR   HOVERGEN; HBG051627; -.
DR   InParanoid; Q13045; -.
DR   OMA; EEEFGHF; -.
DR   OrthoDB; EOG4TB49G; -.
DR   PhylomeDB; Q13045; -.
DR   NextBio; 9397; -.
DR   ArrayExpress; Q13045; -.
DR   Bgee; Q13045; -.
DR   CleanEx; HS_FLII; -.
DR   Genevestigator; Q13045; -.
DR   GermOnline; ENSG00000177731; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003779; F:actin binding; TAS:ProtInc.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   InterPro; IPR007122; Gelsolin.
DR   InterPro; IPR007123; Gelsolin_dom.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   PANTHER; PTHR11977; Gelsolin; 1.
DR   Pfam; PF00626; Gelsolin; 4.
DR   Pfam; PF00560; LRR_1; 1.
DR   PRINTS; PR00597; GELSOLIN.
DR   SMART; SM00262; GEL; 6.
DR   SMART; SM00369; LRR_TYP; 1.
DR   PROSITE; PS51450; LRR; 11.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Activator; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Direct protein sequencing;
KW   Leucine-rich repeat; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   CHAIN         1   1269       Protein flightless-1 homolog.
FT                                /FTId=PRO_0000218750.
FT   REPEAT        7     32       LRR 1.
FT   REPEAT       33     55       LRR 2.
FT   REPEAT       56     78       LRR 3.
FT   REPEAT       80    103       LRR 4.
FT   REPEAT      104    126       LRR 5.
FT   REPEAT      127    149       LRR 6.
FT   REPEAT      150    173       LRR 7.
FT   REPEAT      175    196       LRR 8.
FT   REPEAT      197    222       LRR 9.
FT   REPEAT      223    245       LRR 10.
FT   REPEAT      247    268       LRR 11.
FT   REPEAT      269    291       LRR 12.
FT   REPEAT      293    316       LRR 13.
FT   REPEAT      318    339       LRR 14.
FT   REPEAT      340    363       LRR 15.
FT   REPEAT      501    559       Gelsolin-like 1.
FT   REPEAT      640    670       Gelsolin-like 2.
FT   REPEAT      755    798       Gelsolin-like 3.
FT   REPEAT     1068   1115       Gelsolin-like 4.
FT   REPEAT     1176   1218       Gelsolin-like 5.
FT   REGION        1    427       Interaction with LRRFIP1 and LRRFIP2.
FT   REGION      495    827       Interaction with ACTL6A.
FT   COMPBIAS    411    415       Poly-Ala.
FT   COMPBIAS    892    978       Glu-rich.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES      21     21       N6-acetyllysine.
FT   MOD_RES     406    406       Phosphoserine.
FT   MOD_RES     436    436       Phosphoserine; by SGK3.
FT   MOD_RES     818    818       Phosphothreonine; by SGK3.
FT   MOD_RES     856    856       Phosphoserine.
FT   VARIANT    1243   1243       R -> H (in dbSNP:rs8821).
FT                                /FTId=VAR_029258.
FT   MUTAGEN     586    586       E->K: No change in ESR1 binding but
FT                                reduced binding to ACTL6A and reduced
FT                                coactivator function.
FT   MUTAGEN     603    603       G->S: No change in binding to ACTL6A or
FT                                in coactivator function.
SQ   SEQUENCE   1269 AA;  144751 MW;  29AC7C07738B7B47 CRC64;
     MEATGVLPFV RGVDLSGNDF KGGYFPENVK AMTSLRWLKL NRTGLCYLPE ELAALQKLEH
     LSVSHNNLTT LHGELSSLPS LRAIVARANS LKNSGVPDDI FKLDDLSVLD LSHNQLTECP
     RELENAKNML VLNLSHNSID TIPNQLFINL TDLLYLDLSE NRLESLPPQM RRLVHLQTLV
     LNGNPLLHAQ LRQLPAMTAL QTLHLRSTQR TQSNLPTSLE GLSNLADVDL SCNDLTRVPE
     CLYTLPSLRR LNLSSNQITE LSLCIDQWVH VETLNLSRNQ LTSLPSAICK LSKLKKLYLN
     SNKLDFDGLP SGIGKLTNLE EFMAANNNLE LVPESLCRCP KLRKLVLNKN HLVTLPEAIH
     FLTEIEVLDV RENPNLVMPP KPADRAAEWY NIDFSLQNQL RLAGASPATV AAAAAAGSGP
     KDPMARKMRL RRRKDSAQDD QAKQVLKGMS DVAQEKNKKQ EESADARAPS GKVRRWDQGL
     EKPRLDYSEF FTEDVGQLPG LTIWQIENFV PVLVEEAFHG KFYEADCYIV LKTFLDDSGS
     LNWEIYYWIG GEATLDKKAC SAIHAVNLRN YLGAECRTVR EEMGDESEEF LQVFDNDISY
     IEGGTASGFY TVEDTHYVTR MYRVYGKKNI KLEPVPLKGT SLDPRFVFLL DRGLDIYVWR
     GAQATLSSTT KARLFAEKIN KNERKGKAEI TLLVQGQELP EFWEALGGEP SEIKKHVPED
     FWPPQPKLYK VGLGLGYLEL PQINYKLSVE HKQRPKVELM PRMRLLQSLL DTRCVYILDC
     WSDVFIWLGR KSPRLVRAAA LKLGQELCGM LHRPRHATVS RSLEGTEAQV FKAKFKNWDD
     VLTVDYTRNA EAVLQSPGLS GKVKRDAEKK DQMKADLTAL FLPRQPPMSL AEAEQLMEEW
     NEDLDGMEGF VLEGKKFARL PEEEFGHFYT QDCYVFLCRY WVPVEYEEEE KKEDKEEKAE
     GKEGEEATAE AEEKQPEEDF QCIVYFWQGR EASNMGWLTF TFSLQKKFES LFPGKLEVVR
     MTQQQENPKF LSHFKRKFII HRGKRKAVQG AQQPSLYQIR TNGSALCTRC IQINTDSSLL
     NSEFCFILKV PFESEDNQGI VYAWVGRASD PDEAKLAEDI LNTMFDTSYS KQVINEGEEP
     ENFFWVGIGA QKPYDDDAEY MKHTRLFRCS NEKGYFAVTE KCSDFCQDDL ADDDIMLLDN
     GQEVYMWVGT QTSQVEIKLS LKACQVYIQH MRSKEHERPR RLRLVRKGNE QHAFTRCFHA
     WSAFCKALA
//
